Related Experiment Video
Updated: May 29, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Recent diabetes issues affecting the primary care clinician.
Karen R Sando1, Jose Barboza, Crystal Willis
1University of Florida, College of Pharmacy, Department of Pharmacotherapy and Translational Research, Gainesville 32610, USA. ksando@cop.ufl.edu
Managing type 2 diabetes involves addressing glucose control and related conditions like hypertension and obesity. Primary care physicians must stay updated on new treatments, including liraglutide and saxagliptin, and understand potential issues with metformin and statins.
Area of Science:
- Endocrinology
- Primary Care Medicine
- Pharmacology
Background:
- Type 2 diabetes management requires addressing comorbidities like hypertension, dyslipidemia, and obesity.
- These comorbidities are linked to microvascular and macrovascular complications.
- Primary care clinicians face challenges in staying updated with evolving diabetes literature and treatments.
Purpose of the Study:
- To review current literature on type 2 diabetes management in primary care.
- To discuss key issues including metformin's effect on vitamin B12 absorption.
- To examine recent data on statins and diabetes risk, rosiglitazone's cardiovascular risks, and new treatments like liraglutide and saxagliptin.
Main Methods:
- Review of primary literature.
- Analysis of clinical practice issues.
- Synthesis of data on drug interactions and risks.
Main Results:
- Metformin's impact on vitamin B12 absorption remains a clinical concern.
- Conflicting data exists regarding statins and increased diabetes risk.
- Rosiglitazone is subject to FDA regulations due to cardiovascular risks.
- Liraglutide and saxagliptin offer new therapeutic options for type 2 diabetes.
Conclusions:
- Comprehensive management of type 2 diabetes necessitates attention to comorbidities and potential drug-related issues.
- Emerging treatments provide expanded options for complex patient care.
- Continuous review of scientific literature is crucial for primary care providers.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Complications of Diabetes Mellitus
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational

